About: Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2003

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 2003 (uk) article scientifique publié en 2003 (fr) im Jahr 2003 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2003 (ast) գիտական հոդված հրատարակված 2003 թվականի հունվարի 1-ին (hy) scientific article published on 01 January 2003 (en)
publication date	wds:Q81170227-902EB7C3-7A79-490B-BB68-28A950C3B72A
publication date	2003-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q81170227-E917B060-29A6-4CEF-A1E7-B233733F977A
exact match	https://scigraph.springernature.com/pub.10.1007/s10198-002-0164-z
author name string	wds:Q81170227-101766C7-7FE1-487B-AB85-562879B23BC7 wds:Q81170227-741EFD4E-82EF-4BB4-A9A4-2FA7F060E910 wds:Q81170227-909F9970-FD00-4B0B-BBE3-14388E1D77CF
author name string	Hutton J Zagari M Remák E
rdfs:label	Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK (en) Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK (nl) Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK (sq)
skos:prefLabel	Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK (en) Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK (nl) Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK (sq)
name	Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK (en) Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK (nl) Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK (sq)
author	wds:Q81170227-FE3D73B5-F9BF-4510-983A-8DA90C9F8D57
author	Michael Jones
title	wds:Q81170227-5CFC35A6-7F1E-4309-96C0-0051B59670F7
title	Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK (en)
page(s)	wds:Q81170227-B4F254A7-6CF3-4D31-B549-B11D7083B395
page(s)	115-121
instance of	wds:Q81170227-3763FF11-6D80-402A-81FF-9B6A9AB3ED39
instance of	scholarly article
PubMed ID	wds:Q81170227-F40A3BC6-D793-4E36-AF45-93D798E0380A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15609178
PubMed ID	15609178
published in	wds:Q81170227-21FDDA1D-680E-46DF-9932-F6204FDE6E7F
published in	The European Journal of Health Economics
issue	wds:Q81170227-60915CD9-1C56-4D46-977F-1B59A3A11C5C
volume	wds:Q81170227-21672015-733B-4169-96BF-A33C2E990912
issue	2
volume	4
DOI	wds:Q81170227-E387F0AE-FF95-44FF-BC68-70B196804E06
DOI	http://dx.doi.org/10.1007/S10198-002-0164-Z
DOI	10.1007/S10198-002-0164-Z
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81170227
is cites work of	Utilización de las evaluaciones económicas de intervenciones sanitarias Clinical and economic impact of epoetins in cancer care The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients. Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review Management of anaemia: a critical and systematic review of the cost effectiveness of erythropoiesis-stimulating agents [Are drugs worth their cost?] Probabilistic cost-minimisation analysis of darbepoetin alpha versus epoetin alpha in treating anaemia secondary to chronic renal failure. Assessment in Spanish clinical practice. Treatment of anaemia in cancer patients: implications for supportive care in the National Health Service Cancer Plan
is cites work of	wds:Q35938500-01B32B72-0B27-43B8-9EE1-E00321CC9953 wds:Q92991512-428AAB11-3E94-4C54-8DFF-47F3C63BB26B wds:Q61737695-0D33DA51-1D50-47ED-9E37-A46E329E7641 wds:Q36631500-B8CA80C7-E704-4C8E-B758-AC209E4E28FC wds:Q37588121-EC5A3422-B18B-4CA3-986C-182127596E3B wds:Q83737994-393EE8ED-DE76-4AE5-855C-D26D3A1E21FB wds:Q35579456-F46349B1-2B6A-4B9B-A6A8-8029F8B289F9 wds:Q37058440-D9268CE0-DFF4-43A9-827A-E4460C7E49F3

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software